Nanoliposome-based antibacterial drug delivery.
Although most bacterial infectious diseases can be treated successfully with the remarkable array of antibiotics, the microbial pathogens continue to be one of the most critical health challenges worldwide. One of the common efforts in addressing this issue lies in improving the existing antibacterial delivery systems since inefficient delivery can lead to poor therapeutic outcome of the administered drug. Recently, nanoliposomal systems have been widely used as promising strategies to overcome these challenges due to their unique set of properties. This article tries to briefly summarize the current studies that have taken advantage of liposomal nanoparticles as carriers to deliver antibacterial agents. The reviewed investigations demonstrate the immense potential of liposomal nanoparticles as carriers for antibiotic delivery and highlight the latent promise in this class of vehicles for treatment of bacterial infections. The future of these promising approaches lies in the development of more efficient techniques for preparing liposomal nanoparticles with great potential in effective and selective targeting of antibiotics to bacterial cells for eradication as well as the highest safety for human host.
['Hallaj-Nezhadi|Somayeh|S|', 'Hassan|Maryam|M|']
D000900:Anti-Bacterial Agents D004337:Drug Carriers D016503:Drug Delivery Systems D006801:Humans D008081:Liposomes D053758:Nanoparticles
drug delivery Antibiotic liposome nanoparticle antimicrobial agents